The global Cabergoline API market was valued at US$ 6 million in 2022 and is projected to reach US$ 8 million by 2029, at a CAGR of 4.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global 5 largest manufacturers of Cabergoline API are Teva API, Finetech Pharma, Global Biologicals, Alven Laboratories and Wellona Pharma, which make up over 80%. Among them, Teva API dominates with over 30% production value share, followed by Finetech Pharma (25%) and Global Biologicals (20%). Top manufacturers are based in Israel, China and India.
Europe is the largest market, holding a share nearly 40%, followed by North America and Asia-Pacific, with shares 30% and 20% separately.
Based on the product type, the Cabergoline API is primarily split into Purity below 95%, Purity from 95% to 98% and Purity above 98%. The leading type is Cabergoline API of Purity from 95% to 98%, with a market share nearly 50%.
Based on the product Application, the Cabergoline API is primarily split into Anti-Parkinson, Hyperprolactinemic Disorders and Others. The largest segment is Hyperprolactinemic Disorders, accounting for nearly 75%.
Cabergoline API is the main ingredient of cabergoline in a medicine that causes the desired effect of the medicine. Cabergoline is an ergot derivative and a potent dopamine D2 receptor agonist. Cabergoline was patented in 1980 and approved for medical use in 1993.
This report aims to provide a comprehensive presentation of the global market for Cabergoline API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cabergoline API. This report contains market size and forecasts of Cabergoline API in global, including the following market information:
Global Cabergoline API Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Cabergoline API Market Sales, 2018-2023, 2024-2029, (Kg)
Global top five Cabergoline API companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cabergoline API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cabergoline API Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Cabergoline API Market Segment Percentages, by Type, 2022 (%)
Purity less than 95%
Purity 95%-98%
Purity more than 98%
Global Cabergoline API Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Cabergoline API Market Segment Percentages, by Application, 2022 (%)
Anti-Parkinson
Hyperprolactinemic Disorders
Others
Global Cabergoline API Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Cabergoline API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cabergoline API revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cabergoline API revenues share in global market, 2022 (%)
Key companies Cabergoline API sales in global market, 2018-2023 (Estimated), (Kg)
Key companies Cabergoline API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva API
Finetech Pharma
Global Biologicals
Wellona Pharma
Alven Laboratories
Salvavidas Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cabergoline API, market overview.
Chapter 2: Global Cabergoline API market size in revenue and volume.
Chapter 3: Detailed analysis of Cabergoline API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cabergoline API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cabergoline API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Cabergoline API Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cabergoline API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cabergoline API Overall Market Size
2.1 Global Cabergoline API Market Size: 2022 VS 2029
2.2 Global Cabergoline API Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Cabergoline API Sales: 2018-2029
3 Company Landscape
3.1 Top Cabergoline API Players in Global Market
3.2 Top Global Cabergoline API Companies Ranked by Revenue
3.3 Global Cabergoline API Revenue by Companies
3.4 Global Cabergoline API Sales by Companies
3.5 Global Cabergoline API Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Cabergoline API Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Cabergoline API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cabergoline API Players in Global Market
3.8.1 List of Global Tier 1 Cabergoline API Companies
3.8.2 List of Global Tier 2 and Tier 3 Cabergoline API Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Cabergoline API Market Size Markets, 2022 & 2029
4.1.2 Purity less than 95%
4.1.3 Purity 95%-98%
4.1.4 Purity more than 98%
4.2 By Type - Global Cabergoline API Revenue & Forecasts
4.2.1 By Type - Global Cabergoline API Revenue, 2018-2023
4.2.2 By Type - Global Cabergoline API Revenue, 2024-2029
4.2.3 By Type - Global Cabergoline API Revenue Market Share, 2018-2029
4.3 By Type - Global Cabergoline API Sales & Forecasts
4.3.1 By Type - Global Cabergoline API Sales, 2018-2023
4.3.2 By Type - Global Cabergoline API Sales, 2024-2029
4.3.3 By Type - Global Cabergoline API Sales Market Share, 2018-2029
4.4 By Type - Global Cabergoline API Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cabergoline API Market Size, 2022 & 2029
5.1.2 Anti-Parkinson
5.1.3 Hyperprolactinemic Disorders
5.1.4 Others
5.2 By Application - Global Cabergoline API Revenue & Forecasts
5.2.1 By Application - Global Cabergoline API Revenue, 2018-2023
5.2.2 By Application - Global Cabergoline API Revenue, 2024-2029
5.2.3 By Application - Global Cabergoline API Revenue Market Share, 2018-2029
5.3 By Application - Global Cabergoline API Sales & Forecasts
5.3.1 By Application - Global Cabergoline API Sales, 2018-2023
5.3.2 By Application - Global Cabergoline API Sales, 2024-2029
5.3.3 By Application - Global Cabergoline API Sales Market Share, 2018-2029
5.4 By Application - Global Cabergoline API Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Cabergoline API Market Size, 2022 & 2029
6.2 By Region - Global Cabergoline API Revenue & Forecasts
6.2.1 By Region - Global Cabergoline API Revenue, 2018-2023
6.2.2 By Region - Global Cabergoline API Revenue, 2024-2029
6.2.3 By Region - Global Cabergoline API Revenue Market Share, 2018-2029
6.3 By Region - Global Cabergoline API Sales & Forecasts
6.3.1 By Region - Global Cabergoline API Sales, 2018-2023
6.3.2 By Region - Global Cabergoline API Sales, 2024-2029
6.3.3 By Region - Global Cabergoline API Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Cabergoline API Revenue, 2018-2029
6.4.2 By Country - North America Cabergoline API Sales, 2018-2029
6.4.3 US Cabergoline API Market Size, 2018-2029
6.4.4 Canada Cabergoline API Market Size, 2018-2029
6.4.5 Mexico Cabergoline API Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Cabergoline API Revenue, 2018-2029
6.5.2 By Country - Europe Cabergoline API Sales, 2018-2029
6.5.3 Germany Cabergoline API Market Size, 2018-2029
6.5.4 France Cabergoline API Market Size, 2018-2029
6.5.5 U.K. Cabergoline API Market Size, 2018-2029
6.5.6 Italy Cabergoline API Market Size, 2018-2029
6.5.7 Russia Cabergoline API Market Size, 2018-2029
6.5.8 Nordic Countries Cabergoline API Market Size, 2018-2029
6.5.9 Benelux Cabergoline API Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Cabergoline API Revenue, 2018-2029
6.6.2 By Region - Asia Cabergoline API Sales, 2018-2029
6.6.3 China Cabergoline API Market Size, 2018-2029
6.6.4 Japan Cabergoline API Market Size, 2018-2029
6.6.5 South Korea Cabergoline API Market Size, 2018-2029
6.6.6 Southeast Asia Cabergoline API Market Size, 2018-2029
6.6.7 India Cabergoline API Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Cabergoline API Revenue, 2018-2029
6.7.2 By Country - South America Cabergoline API Sales, 2018-2029
6.7.3 Brazil Cabergoline API Market Size, 2018-2029
6.7.4 Argentina Cabergoline API Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Cabergoline API Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Cabergoline API Sales, 2018-2029
6.8.3 Turkey Cabergoline API Market Size, 2018-2029
6.8.4 Israel Cabergoline API Market Size, 2018-2029
6.8.5 Saudi Arabia Cabergoline API Market Size, 2018-2029
6.8.6 UAE Cabergoline API Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Teva API
7.1.1 Teva API Company Summary
7.1.2 Teva API Business Overview
7.1.3 Teva API Cabergoline API Major Product Offerings
7.1.4 Teva API Cabergoline API Sales and Revenue in Global (2018-2023)
7.1.5 Teva API Key News & Latest Developments
7.2 Finetech Pharma
7.2.1 Finetech Pharma Company Summary
7.2.2 Finetech Pharma Business Overview
7.2.3 Finetech Pharma Cabergoline API Major Product Offerings
7.2.4 Finetech Pharma Cabergoline API Sales and Revenue in Global (2018-2023)
7.2.5 Finetech Pharma Key News & Latest Developments
7.3 Global Biologicals
7.3.1 Global Biologicals Company Summary
7.3.2 Global Biologicals Business Overview
7.3.3 Global Biologicals Cabergoline API Major Product Offerings
7.3.4 Global Biologicals Cabergoline API Sales and Revenue in Global (2018-2023)
7.3.5 Global Biologicals Key News & Latest Developments
7.4 Wellona Pharma
7.4.1 Wellona Pharma Company Summary
7.4.2 Wellona Pharma Business Overview
7.4.3 Wellona Pharma Cabergoline API Major Product Offerings
7.4.4 Wellona Pharma Cabergoline API Sales and Revenue in Global (2018-2023)
7.4.5 Wellona Pharma Key News & Latest Developments
7.5 Alven Laboratories
7.5.1 Alven Laboratories Company Summary
7.5.2 Alven Laboratories Business Overview
7.5.3 Alven Laboratories Cabergoline API Major Product Offerings
7.5.4 Alven Laboratories Cabergoline API Sales and Revenue in Global (2018-2023)
7.5.5 Alven Laboratories Key News & Latest Developments
7.6 Salvavidas Pharmaceutical
7.6.1 Salvavidas Pharmaceutical Company Summary
7.6.2 Salvavidas Pharmaceutical Business Overview
7.6.3 Salvavidas Pharmaceutical Cabergoline API Major Product Offerings
7.6.4 Salvavidas Pharmaceutical Cabergoline API Sales and Revenue in Global (2018-2023)
7.6.5 Salvavidas Pharmaceutical Key News & Latest Developments
8 Global Cabergoline API Production Capacity, Analysis
8.1 Global Cabergoline API Production Capacity, 2018-2029
8.2 Cabergoline API Production Capacity of Key Manufacturers in Global Market
8.3 Global Cabergoline API Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cabergoline API Supply Chain Analysis
10.1 Cabergoline API Industry Value Chain
10.2 Cabergoline API Upstream Market
10.3 Cabergoline API Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cabergoline API Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
116
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report